Exscientia PLC EXAI
We take great care to ensure that the data presented and summarized in this overview for Exscientia plc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding EXAI
View all-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$27.5 Million0.13% of portfolio
-
Sb Global Advisers LTD London, X05.68MShares$27.5 Million3.51% of portfolio
-
Laurion Capital Management LP New York, NY4.47MShares$21.6 Million0.3% of portfolio
-
Baillie Gifford & CO3.85MShares$18.6 Million0.01% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.59MShares$7.7 Million17.85% of portfolio
-
Mic Capital Management Uk LLP London, X01.54MShares$7.47 Million1.14% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.5MShares$7.24 Million0.01% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C31.46MShares$7.05 Million0.33% of portfolio
-
Goldman Sachs Group Inc New York, NY890KShares$4.31 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3860KShares$4.16 Million4.08% of portfolio
Latest Institutional Activity in EXAI
Top Purchases
Top Sells
About EXAI
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Insider Transactions at EXAI
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|